Cargando…
Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344481/ https://www.ncbi.nlm.nih.gov/pubmed/37306432 http://dx.doi.org/10.1097/CM9.0000000000002735 |
_version_ | 1785072876319145984 |
---|---|
author | Yan, Wenqiang Fan, Huishou Xu, Jingyu Liu, Jiahui Li, Lingna Du, Chenxing Deng, Shuhui Sui, Weiwei Xu, Yan Zou, Dehui Qiu, Lugui An, Gang |
author_facet | Yan, Wenqiang Fan, Huishou Xu, Jingyu Liu, Jiahui Li, Lingna Du, Chenxing Deng, Shuhui Sui, Weiwei Xu, Yan Zou, Dehui Qiu, Lugui An, Gang |
author_sort | Yan, Wenqiang |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10344481 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-103444812023-07-20 Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma Yan, Wenqiang Fan, Huishou Xu, Jingyu Liu, Jiahui Li, Lingna Du, Chenxing Deng, Shuhui Sui, Weiwei Xu, Yan Zou, Dehui Qiu, Lugui An, Gang Chin Med J (Engl) Correspondence Lippincott Williams & Wilkins 2023-06-09 2023-07-20 /pmc/articles/PMC10344481/ /pubmed/37306432 http://dx.doi.org/10.1097/CM9.0000000000002735 Text en Copyright © 2023 The Chinese Medical Association, produced by Wolters Kluwer, Inc. under the CC-BY-NC-ND license. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. http://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Correspondence Yan, Wenqiang Fan, Huishou Xu, Jingyu Liu, Jiahui Li, Lingna Du, Chenxing Deng, Shuhui Sui, Weiwei Xu, Yan Zou, Dehui Qiu, Lugui An, Gang Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma |
title | Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma |
title_full | Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma |
title_fullStr | Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma |
title_full_unstemmed | Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma |
title_short | Prognostic value of the Second Revision of the International Staging System (R2-ISS) in a real-world cohort of patients with newly-diagnosed multiple myeloma |
title_sort | prognostic value of the second revision of the international staging system (r2-iss) in a real-world cohort of patients with newly-diagnosed multiple myeloma |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10344481/ https://www.ncbi.nlm.nih.gov/pubmed/37306432 http://dx.doi.org/10.1097/CM9.0000000000002735 |
work_keys_str_mv | AT yanwenqiang prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma AT fanhuishou prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma AT xujingyu prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma AT liujiahui prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma AT lilingna prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma AT duchenxing prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma AT dengshuhui prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma AT suiweiwei prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma AT xuyan prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma AT zoudehui prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma AT qiulugui prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma AT angang prognosticvalueofthesecondrevisionoftheinternationalstagingsystemr2issinarealworldcohortofpatientswithnewlydiagnosedmultiplemyeloma |